The present application is directed to radiolabeled cyclic polypeptides, pharmaceutical compositions comprising radiolabeled cyclic polypeptides, and methods of using the radiolabeled cyclic polypeptides. Such polypeptides can be used in imaging studies, such as Positron Emitting Tomography (PET) or Single Photon Emission Computed Tomography (SPECT).

 
Web www.patentalert.com

< Method and apparatus for analyzing bioprocess fluids

< Method for screening crystallization conditions in solution crystal growth

> PPAR active compounds

> Anticalins

~ 00604